“…This procedure confirmed the prevalence of cortical dysplasia at the roof of the fourth ventricle and revealed an increase in the size of the soma and an atrophy in the complexity of BG cells and astrocyte processes (Figure 3). The morphology of BG and astrocytes showed changes in their soma and processes, which were retracted and diffuse (Figure 3C,D), similar to that reported previously at postnatal age P5 [20], therefore, we measured different characteristics of these cells: BG showed significant differences for soma diameter (Ctrl 10.20 ± 0.68 µm, Carmustine 13.55 ± 0.72 µm) **, area (Ctrl 63.99 ± 7.95 µm, Carmustine 109.60 ± 9.33 µm) * and perimeter of the soma (Ctrl 26.14 ± 1.78 µm, Carmustine 39.20 ± 1.33 µm) **, as well as for process length (Ctrl 58.11 ± 2.56 µm, Carmustine 48.92 ± 3.09 µm) * and process protrusion length (Ctrl 3.88 ± 0.30 µm, Carmustine 2.24 ± 0.26 µm) **; while no significant difference was found in the number of processes (Ctrl 4.36 ± 0.43, Carmustine 3.45 ± 0.36) (1 to 3 BG cells were analyzed from each experiment, n = 6 for control mice and n = 6 for carmustine-treated mice). In astrocytes, the analysis showed that there is a significant difference for the soma diameter (Ctrl 16.42 ± 0.69 µm, Carmustine 23.48 ± 0.55 µm) **, area (Ctrl 142.65 ± 7.61 µm, Carmustine 253.79 ± 8.37 µm) ** and perimeter (Ctrl 45.76 ± 1.58 µm, Carmustine 58.95 ± 1.17 µm) **, as well as for the number (Ctrl 7.68 ± 0.26 µm, Carmustine 5.31 ± 0.14 µm) ** and length of the processes (Ctrl 61.04 ± 1.30 µm, Carmustine 33.29 ± 0.74 µm) ** (six to eight astrocyte cells were analyzed from each experiment, n = 6 for control mice and n = 6 for carmustine-treated mice).…”